Allozyne

Allozyne is a small biotechnology company based in Seattle, Washington. With a team of 3 employees, Allozyne focuses on developing innovative solutions for the creation of new biologics. The company's revenue exceeds $10,000. Allozyne's technology platforms enable the incorporation of amino acid analogues at any position within biologics. This unique approach allows for the development of biologics with enhanced efficacy, tolerability, and pharmacology. Allozyne targets key disease areas through its pipeline of promising products. Allozyne distinguishes itself through its commitment to innovation and growth, evident in both its technology platforms and product pipeline. The company's ability to modify biologics at a fundamental level opens up new possibilities for treating diseases more effectively. For more information about Allozyne and its groundbreaking work, visit their website at allozyne.com.